10 Best Building Product Stocks To Invest In 2014

Dublin, Ireland-based heavy industrial manufacturer Ingersoll-Rand (NYSE: IR  ) is laying the groundwork for spinning off its Indiana-based, Ireland-registered Allegion subsidiary.

On Tuesday, Ingersoll named Quanex Building Products (NYSE: NX  ) CEO David�D. Petratis as the new chairman, president, and CEO of its soon-to-spin-off Allegion subsidiary. Petratis has served as chairman, president, and CEO of Houston-based Quanex since July 2008.

In announcing Petratis' appointment, Ingersoll-Rand CEO Michael W. Lamach called him "an accomplished leader in the manufacturing and marketing of code-compliant, high-value products that are specified by architects and engineers, and used by commercial and residential builders." Lamach also expressed hope that his "vision and leadership [will] help realize Allegion's full potential."

Based in Carmel, Ind., global security products and solutions company Allegion aims to list its shares on the New York Stock Exchange, using the ticker symbol ALLE. Post-spinoff, the company will boast $2 billion in annual sales of such products as steel doors and locks. This transaction is expected to take place by year's end.

Top 10 India Stocks To Watch For 2015: Mears Group PLC (MER)

Mears Group PLC (Mears Group) is a holding company. The principal activities of the Company are the provision of a range of outsourced services to the public and private sectors. The Company operated in three business segments: social housing, which provides a full repair and maintenance service to local authorities and other registered social housing landlords in the United Kingdom; domiciliary care, which provides personal care services to people in their own homes and mechanical and electrical (M&E), which consists of provision of design and build M&E services. The Company�� subsidiaries include Mears Limited, Haydon Mechanical & Electrical Limited, Scion Technical Services Limited, Scion Estates Limited, Jackson Lloyd Limited, Morrison Facilities Services Limited, Morrison Facilities Services Limited, Manchester Working Limited and Mears Home Improvements Limited. Effective August 13, 2013, Mears Group PLC acquired a 50% interest in Just Call 24/7 (UK) Ltd. Advisors' Opinion:

• [By John Heinzl]

  If you're uncomfortable picking individual preferred shares, a diversified exchange-traded fund, such as CPD can be a good option. The fund, which has about $1.4-billion under management, holds more than 200 preferred shares, with banks and insurance companies accounting for more than half of the assets. The fund has a management expense ratio (MER) of 0.5%.

10 Best Building Product Stocks To Invest In 2014: NuPathe Inc.(PATH)

NuPathe Inc., a specialty pharmaceutical company, focuses on the development and commercialization of branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. The company?s advanced product candidate includes Zelrix an active single-use transdermal sumatriptan patch that is used for the treatment of migraine. Its proprietary product candidates in preclinical development stage comprise NP201 for the continuous symptomatic treatment of Parkinson?s disease; and NP202 for the long-term treatment of schizophrenia and bipolar disorder. NuPathe Inc. was founded in 2005 and is headquartered in Conshohocken, Pennsylvania.

Advisors' Opinion:

• [By Vanina Egea] lli revealed owning a stake of 1,313,500 NuPathe Inc. shares, worth 0.01% of his portfolio. NuPathe Inc. has a market cap of $142 million; its shares are trading currently at around $4.3 with a P/B ratio of 18.4.

  NuPathe is a specialty pharmaceutical company, focusing on the development and commercialization of branded therapeutics for neurological and psychiatric disorders. Teva Pharmaceutical Industries Ltd. (TEVA) announced a tender offer for all of the outstanding shares of common stock at a price of $3.65 per share in cash, and NuPathe stockholders will receive rights to receive additional cash payments of up to $3.15 per share The firm will become a wholly owned subsidiary of Teva, and common stock will cease to be traded on the Nasdaq following completion of the merger.

  Hedge fund gurus have also been active in the company: Jim Simons (Trades, Portfolio) and Ronald Muhlenkamp (Trades, Portfolio) have invested in it.

  ATMI Inc. (ATMI)

  Gabelli reported a stake of 1,193,900 shares of ATMI Inc., sized at 0.22% of his portfolio, and 3.75% of the company. It has a market cap of $1.08 billion; its shares are trading at $34.04 with a P/E ratio of 28.6 and P/S ratio of 2.77.

  ATMI supplies high performance materials, materials packaging and materials delivery systems for use in the manufacture of microelectronics devices worldwide. ATMI agreed to be acquired by Entegris (ENTG) for $1.15 billion, or $34 per share. The deal will provide a lot more of product offerings. The acquisition is expected to close during the second calendar quarter of 2014.

  Hedge fund gurus have also been active in the company. Jim Simons (Trades, Portfolio), Arnold Schneider (Trades, Portfolio) and Paul Tudor Jones (Trades, Portfolio) have divested in it in the last quarter.

  Nobility Homes Inc. (NOBH)

  Finally, Gabelli reported owning 234.950 shares of Nobility Homes, sized at 5.97% of the company�� shares outstanding and 0.01% of Gabelli�

10 Best Building Product Stocks To Invest In 2014: Triangle Capital Corporation (TCAP)

Triangle Capital Corporation is a private equity and venture capital firm specializing in leveraged buyouts, management buyouts, ESOPs, change of control transactions, acquisition financings, growth financing, and recapitalizations in lower middle market companies. The firm prefers to make investments in many business sectors including manufacturing, distribution, transportation, energy, communications, health services, restaurants, media, and others. It primarily invests in companies located throughout the United States, with an emphasis on the Southeast and Midatlantic. The firm typically invests between $5 million and $20 million per transaction, in companies having annual revenues between $10 million and $200 million and an EBITDA between $3 million and $20 million and can also co-invest. It primarily invests in senior subordinated debt securities secured by second lien security interests in portfolio company assets, coupled with equity interests. The firm also invests in senior debt securities secured by first lien security interests in portfolio companies. Triangle Capital Corporation was founded in 2002 and is based in Raleigh, North Carolina.

Advisors' Opinion:

• [By BDC Buzz]

  FDUS is one of the few BDCs to consistently grow its NAV on a quarterly basis over the last two years. This is because most BDCs are regulated investment companies ("RIC") required to distribute at least 90% of capital gains, dividends and interest to shareholders to avoid taxation at the corporate level and 98% of net investment income to avoid paying a 4% excise tax. Excluding American Capital (ACAS) which converted from a RIC to a Subchapter C and does not pay a dividend, only a few BDCs have been able to pay a healthy dividend while increasing value per share - as discussed in "Triangle Capital: Is It Priced For Total Return?" including Main Street Capital (MAIN) and Triangle Capital (TCAP).

• [By Eric Volkman]

  Triangle Capital (NYSE: TCAP  ) is continuing to set aside money to return to shareholders. The company has declared its latest quarterly dividend, which is to be $0.54 per share paid on June 26 to shareholders of record as of June 12. That amount matches the firm's previous distribution, which was paid in late March. Prior to that, it handed out $0.53 per share.

• [By Helix Investment Research]

  Much has been made over Keating Capital's fee structure, and suggestions that company executives are using it as a "personal ATM" to funnel shareholder money to Keating Investments, Keating Capital's investment adviser (Keating Capital is an externally managed business development company). However, Keating's fees are not exorbitant, at least in comparison to the industry average. Per data sourced from Triangle Capital (TCAP), the average externally managed BDC has a management fee of 1.75%-2% of gross assets, and an incentive fee of 20%. Keating Capital's fee structure includes a 2% management fee, and a 20% incentive fee, in line with the industry average. The formula below represents Keating Capital's incentive fee:

10 Best Building Product Stocks To Invest In 2014: Lenovo Group Ltd (LNVGF.PK)

Lenovo Group Limited is principally engaged in investment holding. It is a personal technology company serving customers in more than 160 countries. The Company is a personal computer (PC) vendor. The Company develops, manufactures and markets technology products and services. Its product lines include Think-branded commercial PCs and Idea branded consumer PCs, as well as servers, workstations, and a family of mobile Internet devices, including tablets and smart phones. It offers a range of commercial desktops and notebooks to businesses of all sizes that feature cutting-edge technology, customer-centric innovation and productivity features. It operates in three segments: China, Emerging Markets (excluding China) and Mature Markets. Lenovo has research centers in Yamato, Japan; Beijing, Shanghai and Shenzhen, China; and Raleigh, North Carolina, the United States. Advisors' Opinion:

• [By Investometrica]

  x86: With regards to the specific x86 server business, it seems that IBM is considering the possibility of fully divesting it. According to Morgan Stanley, the server business generated about $4.9 billion of the company's $15.4 billion in server sales last year. This enormous volume is due to the fact that IBM may be producing the overall market's highest volumes, at the lowest profit level; which suggests this segment is doomed. Finally, IBM has a history of aggressive shifts to areas with better growth prospects and margins. For example, the company agreed to sell off the PC business to Lenovo (LNVGF.PK) at a moment where the PC still seemed attractive.

10 Best Building Product Stocks To Invest In 2014: KKR(KKR)

Kohlberg Kravis Roberts & Co. is a private equity and venture capital firm specializing in acquisitions, leveraged buyouts, management buyouts, and mezzanine investments in large cap companies. The firm will consider investments in all industries globally, with a focus on financial services, infrastructure, and renewable energy. It seeks a board seat in its portfolio companies. The firm holds a controlling interest in its portfolio companies after they go public. It typically holds its investment for a period of five years and more and exits through initial public offerings, secondary offerings, and sales to strategic buyers. Kohlberg Kravis Roberts & Co. was founded in 1976 and is based at New York, New York with additional offices across United States, Europe, Australia, and Asia.

Advisors' Opinion:

• [By Reuters]

  Itsuo Inouye/APA Panasonic 150-inch high-definition plasma TV on display at a 2008 expo in Tokyo. TOKYO -- Panasonic will pull out of the plasma television panel business by the end of the financial year to March 2014, sources familiar with the situation told Reuters, marking a key milestone in the long-term decline of Japan's TV industry. Panasonic had been widely expected to back out of the unprofitable business, but the exit comes sooner than predicted and underlines President Kazuhiro Tsuga's determination to weed out weak operations as he focuses on higher-margin products to end years of losses at the consumer electronics conglomerate. Panasonic's TV division has been a major contributor to the electronics company's combined $15 billion (9 billion pounds) net loss in its two latest financial years. Its TV business posted an operating loss of 88.5 billion yen ($913 million) in the last financial year. With the closure of its sole plasma panel factory in western Japan, Panasonic will book an impairment loss of more than 40 billion yen on the last remaining factory building in operation, the sources added. The company set aside 120 billion yen to cover restructuring costs at the start of the current financial year. The move also signals the demise in Japan of a technology in which TV makers once invested heavily but has now been overtaken by advances in the liquid crystal display business. Plasma display TVs accounted for less than 6 percent of global shipments in 2012, compared with 87 percent for LCD TVs, according to research firm DisplaySearch. Squeezed by the strong yen in recent years, Japan's TV makers have also lost their innovative edge against nimbler rivals such as South Korea's Samsung Electronics, with deep resources to spend on research and development. Sony (SNE), Panasonic and Sharp combined had a less than 20 percent share of the worldwide flat panel TV market by revenue. Samsung had a 27.7 percent share, and LG Electronics had 15 pe

• [By Rich Smith]

  The Wall Street Journal calls Carlsbad, Calif.-based Life Technologies (NASDAQ: LIFE  ) an $11 billion "company you never heard of." As the Journal reports, a buyout group including private-equity powerhouses Blackstone (NYSE: BX  ) , Carlyle Group (NASDAQ: CG  ) , and KKR (NYSE: KKR  ) is putting together an $11 billion bid to acquire the lab research equipment manufacturer. But as it turns out, Life is doing a bit of acquiring itself.

10 Best Building Product Stocks To Invest In 2014: Bellway PLC (BWY)

Bellway p.l.c. is a United Kingdom-based holding company, owning subsidiary undertakings, which is engaged principally in housebuilding in the United Kingdom. The Company�� subsidiaries include Bellway Homes Limited, Bellway Properties Limited, Bellway (Services) Limited, Litrose Investments Limited, Bellway Financial Services Limited, Bellway Housing Trust Limited and The Victoria Dock Company Limited. Advisors' Opinion:

• [By Sofia Horta e Costa]

  Persimmon dropped 4.3 percent to 1,061 pence, while Bellway Plc (BWY) declined 3.1 percent to 1,262 pence. Bovis Homes Group Plc slipped 2.7 percent to 712 pence. Chancellor of the Exchequer George Osborne and the Bank of England will reassess the Help-to-Buy program, which allows the purchase of homes with a deposit as small as 5 percent, every September from 2014, the Treasury said.

• [By Sofia Horta e Costa]

  Bellway Plc (BWY) added 1.4 percent after the homebuilder said reservations in the past four months rose 31 percent as buyers had greater access to mortgages. Elan (ELN) Corp. jumped to a 10-month high in Dublin after Royalty Pharma increased its offer for the Irish drugmaker to as much as $6.7 billion. BT Group increased 3.7 percent as Barclays Plc recommended investors buy shares of the U.K.�� largest fixed-line company.

10 Best Building Product Stocks To Invest In 2014: Keryx Biopharmaceuticals Inc.(KERX)

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment cancer and renal disease. The company?s products under development include KRX-0401 (perifosine), an oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, as well as affects other pathways associated with programmed cell death, cell growth, cell differentiation, and cell survival. Its KRX-0401 is in Phase III clinical development stage for the treatment of refractory advanced colorectal cancer and multiple myeloma, as well as in Phase I and Phase II clinical development stages for the treatment of other tumor types. The company is also developing Zerenex (ferric citrate), an oral, ferric iron-based compound that is in Phase III clinical development for the treatment of hyperphosphatemia in patients with end-stage renal disease o n dialysis. Keryx Biopharmaceuticals, Inc. has commercial license agreements with Zentaris AG for the development of KRX-0401; Panion & BF Biotech, Inc. for the development and marketing of Zerenex; and Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of Zerenex in Japan. The company was founded in 1997 and is based in New York, New York.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Leading and Lagging Sectors
  Healthcare sector moved up 0.39 percent, with Keryx Biopharmaceuticals (NASDAQ: KERX) moving up 15 percent to gain the top spot. Top gainers in the sector included China Biologic Products (NASDAQ: CBPO), with shares up 7.4 percent, and Laboratory Corp. of America Holdings (NYSE: LH), with shares up 5.5 percent.

• [By Sean Williams]

  What: Shares of Keryx Biopharmaceuticals (NASDAQ: KERX  ) , a biopharmaceutical company focused on developing therapies to treat renal diseases, plunged as much as 12% after announcing midday Friday that Ferric Citrate (previously known as Zerenex) has been approved by the Food and Drug Administration as an oral iron-based treatment for dialysis patients with hyperphosphatemia.

• [By MONEYMORNING]

  Case in point: Keryx Biopharmaceuticals (Nasdaq: KERX) is a small biotech (market cap: $1.29B) with an experimental drug, Zerenex, that treats elevated phosphate levels and iron deficiency anemia in patients on dialysis for advanced chronic kidney disease (CKD).

• [By Keith Speights]

  There were definitely some good parts in what Keryx Biopharmaceuticals (NASDAQ: KERX  ) had to say at this week's Stifel Nicolaus Weisel Healthcare Conference in Boston. A lot was said, but here are the three highlights you'll want to know about.